Coca-Cola Europacific Partners PLC (LON:CCEP - Get Free Report)'s share price shot up 1.9% during mid-day trading on Monday . The company traded as high as GBX 6,560 ($85.34) and last traded at GBX 6,540 ($85.08). 131,614 shares traded hands during mid-day trading, a decline of 29% from the average session volume of 186,159 shares. The stock had previously closed at GBX 6,420 ($83.52).
Coca-Cola Europacific Partners Price Performance
The firm has a 50 day moving average of GBX 6,478.25 and a two-hundred day moving average of GBX 4,679.32. The company has a current ratio of 0.85, a quick ratio of 0.66 and a debt-to-equity ratio of 144.80. The stock has a market capitalization of £36.58 billion, a PE ratio of 22.71, a P/E/G ratio of 1.94 and a beta of 0.75.
Coca-Cola Europacific Partners Company Profile
(
Get Free Report)
Coca-Cola Europacific Partners is the world's largest independent Coca-Cola bottler by revenue. Our employees make, sell and distribute the world's most loved drinks brands, serving a consumer population of more than 600 million across 29 markets.
Further Reading
Before you consider Coca-Cola Europacific Partners, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Coca-Cola Europacific Partners wasn't on the list.
While Coca-Cola Europacific Partners currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
